A clinical-stage biotechnology company developing immunologic therapies designed to modulate the body’s innate immune response, with programs targeting viral infections and other inflammatory conditions. Its pipeline includes intranasal and systemic candidates intended to stimulate protective immune...
Market Cap: $1.9M52W Range: $1.19 – $44.77
This page tracks all publicly disclosed congressional trades in Revelation Biosciences, Inc. (REVB), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 0 purchases and 13 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.